spacer
spacer
Go to PDB code: 
protein ligands links
Hormone/growth factor PDB id
1q1u
Jmol
Contents
Protein chain
138 a.a. *
Ligands
SO4 ×4
Waters ×36
* Residue conservation analysis
PDB id:
1q1u
Name: Hormone/growth factor
Title: Crystal structure of human fhf1b (fgf12b)
Structure: Fibrobast growth factor homologous factor 1. Chain: a. Fragment: residues 1-144. Synonym: fgf-12. Fgf12b. Fibroblast growth factor 12 isoform 2. Myocyte-activating factor. Fgf12 protein. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Other_details: t7 promoter driven expression
Resolution:
1.70Å     R-factor:   0.223     R-free:   0.240
Authors: S.K.Olsen,M.Garbi,N.Zampieri,A.V.Eliseenkova,D.M.Ornitz, M.Goldfarb,M.Mohammadi
Key ref:
S.K.Olsen et al. (2003). Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J Biol Chem, 278, 34226-34236. PubMed id: 12815063 DOI: 10.1074/jbc.M303183200
Date:
22-Jul-03     Release date:   05-Aug-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P61328  (FGF12_HUMAN) -  Fibroblast growth factor 12
Seq:
Struc:
243 a.a.
138 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Biochemical function     growth factor activity     1 term  

 

 
DOI no: 10.1074/jbc.M303183200 J Biol Chem 278:34226-34236 (2003)
PubMed id: 12815063  
 
 
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
S.K.Olsen, M.Garbi, N.Zampieri, A.V.Eliseenkova, D.M.Ornitz, M.Goldfarb, M.Mohammadi.
 
  ABSTRACT  
 
Fibroblast growth factors (FGFs) interact with heparan sulfate glycosaminoglycans and the extracellular domains of FGF cell surface receptors (FGFRs) to trigger receptor activation and biological responses. FGF homologous factors (FHF1-FHF4; also known as FGF11-FGF14) are related to FGFs by substantial sequence homology, yet their only documented interactions are with an intracellular kinase scaffold protein, islet brain-2 (IB2) and with voltage-gated sodium channels. In this report, we show that recombinant FHFs can bind heparin with high affinity like classical FGFs yet fail to activate any of the seven principal FGFRs. Instead, we demonstrate that FHFs bind IB2 directly, furthering the contention that FHFs and FGFs elicit their biological effects by binding to different protein partners. To understand the molecular basis for this differential target binding specificity, we elucidated the crystal structure of FHF1b to 1.7-A resolution. The FHF1b core domain assumes a beta-trefoil fold consisting of 12 antiparallel beta strands (beta 1 through beta 12). The FHF1b beta-trefoil core is remarkably similar to that of classical FGFs and exhibits an FGF-characteristic heparin-binding surface as attested to by the number of bound sulfate ions. Using molecular modeling and structure-based mutational analysis, we identified two surface residues, Arg52 in the beta 4-beta 5 loop and Val95 in the beta 9 strand of FHF1b that are required for the interaction of FHF1b with IB2. These two residues are unique to FHFs, and mutations of the corresponding residues of FGF1 to Arg and Val diminish the capacity of FGF1 to activate FGFRs, suggesting that these two FHF residues contribute to the inability of FHFs to activate FGFRs. Hence, FHFs and FGFs bear striking structural similarity but have diverged to direct related surfaces toward interaction with distinct protein targets.
 
  Selected figure(s)  
 
Figure 3.
FIG. 3. FHF1b binds IB2 directly. Recombinant FHFs were mixed with partially purified mIB2[226-421] at a 1:3 molar ratio and chromatographed through a Superdex 75 gel filtration column. Fractions were analyzed by SDS-PAGE followed by silver staining. A, FHF1b only; B, FHF1b + mIB2[226-421]; C, FHF4b only; D, FHF4b + mIB2[226-421]; E, FHF1b[1-142]. Wild-type FHFs alone elute slowly, whereas they co-elute rapidly when complexed with mIB2[226-421].
Figure 5.
FIG. 5. Comparison of FHF1b versus FGF structure. A, stereo view of FHF1b-FGF9 overlay. The C trace of FGF9 -trefoil (blue) was superimposed onto the C trace of the FHF1b -trefoil (orange). The N and C termini are labeled NT and CT, respectively. The [8]- [9] turn of the ligands (discussed under "Results") are marked by an arrowhead. This figure was created using the program MolScript (59). B, stereo view of the electron density map of the FHF1b heparin-binding site. The 2F[o]-F[c] electron density map (contoured at 1.2 ) is shown as white (FHF1b) and cyan (sulfate ions) wire mesh. The FHF1b -trefoil core is shown as a ribbon diagram, and residues that interact with the sulfate ions are rendered as sticks. Ordered sulfate ions are also rendered as sticks. This figure was created using the program PyMOL (56).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2003, 278, 34226-34236) copyright 2003.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21506104 N.A.Sunmonu, K.Li, and J.Y.Li (2011).
Numerous isoforms of Fgf8 reflect its multiple roles in the developing brain.
  J Cell Physiol, 226, 1722-1726.  
20889570 D.C.Tomlinson, and M.A.Knowles (2010).
Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.
  Am J Pathol, 177, 2379-2386.  
20860061 S.Tulin, and A.Stathopoulos (2010).
Extending the family table: Insights from beyond vertebrates into the regulation of embryonic development by FGFs.
  Birth Defects Res C Embryo Today, 90, 214-227.  
19874848 V.Knights, and S.J.Cook (2010).
De-regulated FGF receptors as therapeutic targets in cancer.
  Pharmacol Ther, 125, 105-117.  
19247306 A.Beenken, and M.Mohammadi (2009).
The FGF family: biology, pathophysiology and therapy.
  Nat Rev Drug Discov, 8, 235-253.  
18850329 F.M.Vaccarino, E.L.Grigorenko, K.M.Smith, and H.E.Stevens (2009).
Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism.
  J Autism Dev Disord, 39, 511-520.  
19019915 M.S.Razzaque (2009).
FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?
  Am J Physiol Renal Physiol, 296, F470-F476.  
19621416 P.Krejci, J.Prochazkova, V.Bryja, A.Kozubik, and W.R.Wilcox (2009).
Molecular pathology of the fibroblast growth factor family.
  Hum Mutat, 30, 1245-1255.  
19406745 R.Goetz, K.Dover, F.Laezza, N.Shtraizent, X.Huang, D.Tchetchik, A.V.Eliseenkova, C.F.Xu, T.A.Neubert, D.M.Ornitz, M.Goldfarb, and M.Mohammadi (2009).
Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels.
  J Biol Chem, 284, 17883-17896.
PDB code: 3hbw
19322767 R.Lea, N.Papalopulu, E.Amaya, and K.Dorey (2009).
Temporal and spatial expression of FGF ligands and receptors during Xenopus development.
  Dev Dyn, 238, 1467-1479.  
18930825 V.G.Shakkottai, M.Xiao, L.Xu, M.Wong, J.M.Nerbonne, D.M.Ornitz, and K.A.Yamada (2009).
FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons.
  Neurobiol Dis, 33, 81-88.  
18794802 E.M.Schaeffer, L.Marchionni, Z.Huang, B.Simons, A.Blackman, W.Yu, G.Parmigiani, and D.M.Berman (2008).
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.
  Oncogene, 27, 7180-7191.  
18397341 F.Forconi, G.Poretti, I.Kwee, E.Sozzi, D.Rossi, P.M.Rancoita, D.Capello, A.Rinaldi, E.Zucca, D.Raspadori, V.Spina, F.Lauria, G.Gaidano, and F.Bertoni (2008).
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.
  Br J Haematol, 141, 622-630.  
18525161 F.Nakayama, K.Müller, A.Hagiwara, R.Ridi, M.Akashi, and V.Meineke (2008).
Involvement of intracellular expression of FGF12 in radiation-induced apoptosis in mast cells.
  J Radiat Res (Tokyo), 49, 491-501.  
18991947 G.R.Uhl (2008).
Addiction Reviews. Preface.
  Ann N Y Acad Sci, 1141, ix-ix.  
17878606 S.Fukumoto (2008).
Actions and mode of actions of FGF19 subfamily members.
  Endocr J, 55, 23-31.  
18310961 S.Fukumoto (2008).
Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
  Intern Med, 47, 337-343.  
18220257 T.Hubert, S.Bourane, S.Ventéo, I.Mechaly, S.Puech, J.Valmier, P.Carroll, and A.Fichard-Carroll (2008).
Fibroblast growth factor homologous factor 1 (FHF1) is expressed in a subpopulation of calcitonin gene-related peptide-positive nociceptive neurons in the murine dorsal root ganglia.
  J Comp Neurol, 507, 1588-1601.  
17678857 M.Goldfarb, J.Schoorlemmer, A.Williams, S.Diwakar, Q.Wang, X.Huang, J.Giza, D.Tchetchik, K.Kelley, A.Vega, G.Matthews, P.Rossi, D.M.Ornitz, and E.D'Angelo (2007).
Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels.
  Neuron, 55, 449-463.  
18021009 M.K.Stachowiak, P.A.Maher, and E.K.Stachowiak (2007).
Integrative nuclear signaling in cell development--a role for FGF Receptor-1.
  DNA Cell Biol, 26, 811-826.  
16995857 A.Canales, R.Lozano, B.López-Méndez, J.Angulo, R.Ojeda, P.M.Nieto, M.Martín-Lomas, G.Giménez-Gallego, and J.Jiménez-Barbero (2006).
Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
  FEBS J, 273, 4716-4727.
PDB code: 2erm
16817858 A.M.Rush, E.K.Wittmack, L.Tyrrell, J.A.Black, S.D.Dib-Hajj, and S.G.Waxman (2006).
Differential modulation of sodium channel Na(v)1.6 by two members of the fibroblast growth factor homologous factor 2 subfamily.
  Eur J Neurosci, 23, 2551-2562.  
16470835 W.Zhong, Q.T.Wang, T.Sun, F.Wang, J.Liu, R.Leach, A.Johnson, E.E.Puscheck, and D.A.Rappolee (2006).
FGF ligand family mRNA expression profile for mouse preimplantation embryos, early gestation human placenta, and mouse trophoblast stem cells.
  Mol Reprod Dev, 73, 540-550.  
16597617 X.Zhang, O.A.Ibrahimi, S.K.Olsen, H.Umemori, M.Mohammadi, and D.M.Ornitz (2006).
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
  J Biol Chem, 281, 15694-15700.  
15632285 J.Kim, J.Lee, S.R.Brych, T.M.Logan, and M.Blaber (2005).
Sequence swapping does not result in conformation swapping for the beta4/beta5 and beta8/beta9 beta-hairpin turns in human acidic fibroblast growth factor.
  Protein Sci, 14, 351-359.
PDB codes: 1pzz 1q03 1q04
16166153 J.Y.Lou, F.Laezza, B.R.Gerber, M.Xiao, K.A.Yamada, H.Hartmann, A.M.Craig, J.M.Nerbonne, and D.M.Ornitz (2005).
Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.
  J Physiol, 569, 179-193.  
15863036 M.Goldfarb (2005).
Fibroblast growth factor homologous factors: evolution, structure, and function.
  Cytokine Growth Factor Rev, 16, 215-220.  
15863029 M.Mohammadi, S.K.Olsen, and O.A.Ibrahimi (2005).
Structural basis for fibroblast growth factor receptor activation.
  Cytokine Growth Factor Rev, 16, 107-137.  
15140207 M.Kawano, S.Suzuki, M.Suzuki, J.Oki, and T.Imamura (2004).
Bulge- and basal layer-specific expression of fibroblast growth factor-13 (FHF-2) in mouse skin.
  J Invest Dermatol, 122, 1084-1090.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.